44 Paul Tudor Jones II Johnson & Johnson Trades
Paul Tudor Jones II acquired 37.5 Thousand Johnson & Johnson shares worth $5.78 Million. That's 0.07% of their equity portfolio (348th largest holding). The first Johnson & Johnson trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 36 more times and sold shares on 35 occasions. The investor's estimated purchase price is $6.21 Million, resulting in a loss of 6.8%.
News about Johnson & Johnson and Paul Tudor Jones II
Johnson & Johnson seeks U.S. FDA approval of SPRAVATO® (esketamine) as the first and only monotherapy for adults with treatment-resistant depression
Phase 4 SPRAVATO® monotherapy data shows rapid improvement in depressive symptoms at ~24 hours, sustained through at least 4 weeks Monotherapy submission bui...
J&J: Rybrevant In Combination Gets Approval In Europe For First-Line Treatment Of NSCLC
NEW BRUNSWICK (dpa-AFX) - Janssen-Cilag International NV, a subsidiary of Johnson & Johnson Co. (JNJ), Friday announced that the European Commission has appr...
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden ''s administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This shift...
Europe Approves Reduced Dosing For Johnson & Johnson''s Cell Therapy For Multiple Myeloma
The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ ) announced that the European Commission (EC) approved a Type II variation application f...